TMPRSS2 and metabolic dysfunction-associated steatotic liver disease: Furthermore, non-alcoholic fatty liver disease (NAFLD) is a major comorbidity of obesity, and it has been linked to increased hepatic expression of ACE2 and TMPRSS2 [18], which could contribute to the aggravate morbidity in SARS-CoV-2 patients.